These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33007738)

  • 21. Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.
    Niu J; Zeng M; Wang Y; Liu J; Li H; Wang S; Zhou X; Wang J; Li Y; Hou F; Zhu J
    BMC Cardiovasc Disord; 2020 Jun; 20(1):292. PubMed ID: 32539749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease.
    Saito M; Okayama H; Yoshii T; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Ohtsuka T; Funada J; Shigematsu Y; Higaki J
    Int J Cardiol; 2011 Aug; 150(3):301-6. PubMed ID: 20471702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.
    Dewaswala N; Chen D; Bhopalwala H; Kaggal VC; Murphy SP; Bos JM; Geske JB; Gersh BJ; Ommen SR; Araoz PA; Ackerman MJ; Arruda-Olson AM
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):272. PubMed ID: 36258218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image and DNA analysis of hypertrophic myocytes in hypertensive heart disease and hypertrophic cardiomyopathy.
    Takeda A; Sakata A; Takeda N
    Anal Quant Cytol Histol; 1999 Oct; 21(5):454-7. PubMed ID: 10560530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic cardiomyopathy is associated with more severe left ventricular dyssynchrony than is hypertensive left ventricular hypertrophy.
    Nagakura T; Takeuchi M; Yoshitani H; Nakai H; Nishikage T; Kokumai M; Otani S; Yoshiyama M; Yoshikawa J
    Echocardiography; 2007 Aug; 24(7):677-84. PubMed ID: 17651095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.
    Huurman R; van der Velde N; Schinkel AFL; Hassing HC; Budde RPJ; van Slegtenhorst MA; Verhagen JMA; Hirsch A; Michels M
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1144-1154. PubMed ID: 35670722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can serum carnitine levels distinguish hypertrophic cardiomyopathy from hypertensive hearts?
    Nakamura T; Sugihara H; Kinoshita N; Yoneyama S; Azuma A; Nakagawa M
    Hypertension; 2000 Aug; 36(2):215-9. PubMed ID: 10948080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Diagnosis of Thick Myocardium according to Histologic Features Revealed by Multiparametric Cardiac Magnetic Resonance Imaging.
    Cha MJ; Kim C; Park CH; Hong YJ; Shin JM; Kim TH; Cha YJ; Park CH
    Korean J Radiol; 2022 Jun; 23(6):581-597. PubMed ID: 35555885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.
    Palumbo P; Masedu F; De Cataldo C; Cannizzaro E; Bruno F; Pradella S; Arrigoni F; Valenti M; Splendiani A; Barile A; Giovagnoni A; Masciocchi C; Di Cesare E
    Radiol Med; 2021 Dec; 126(12):1532-1543. PubMed ID: 34894317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.
    Satriano A; Heydari B; Guron N; Fenwick K; Cheung M; Mikami Y; Merchant N; Lydell CP; Howarth AG; Fine NM; White JA
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1913-1924. PubMed ID: 31144257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy.
    Arcari L; Hinojar R; Engel J; Freiwald T; Platschek S; Zainal H; Zhou H; Vasquez M; Keller T; Rolf A; Geiger H; Hauser I; Vogl TJ; Zeiher AM; Volpe M; Nagel E; Puntmann VO
    Int J Cardiol; 2020 May; 306():102-108. PubMed ID: 32169347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.